Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

CRISPR–Cas9 genome editing is used to correct a dominant-negative mutation in a mouse model of inherited deafness, resulting in improvements in cochlear function and hearing. Hindering heritable hearing loss Nearly half of all deafness cases arise from genetic factors, yet there are limited treatmen...

Full description

Saved in:
Bibliographic Details
Published inNature (London) Vol. 553; no. 7687; pp. 217 - 221
Main Authors Gao, Xue, Tao, Yong, Lamas, Veronica, Huang, Mingqian, Yeh, Wei-Hsi, Pan, Bifeng, Hu, Yu-Juan, Hu, Johnny H., Thompson, David B., Shu, Yilai, Li, Yamin, Wang, Hongyang, Yang, Shiming, Xu, Qiaobing, Polley, Daniel B., Liberman, M. Charles, Kong, Wei-Jia, Holt, Jeffrey R., Chen, Zheng-Yi, Liu, David R.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 11.01.2018
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…